Related Experiment Video
Updated: Jul 24, 2026

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis
Published on: January 26, 2024
Identification of activated tumor antigen-reactive CD8+ cells in healthy individuals
T V Lee1, B W Anderson, G E Peoples
1Department of Gynecologic Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Insights
Tumor-associated lymphocytes (TALs) in healthy individuals can be activated by HER-2 peptide E75, producing interferon-gamma (IFN-γ). This suggests a role for these T cells in natural immunosurveillance against tumors.
Area of Science:
- Immunology
- Cancer Research
- Cellular Biology
Background:
- Tumor-associated lymphocytes (TALs) play a role in anti-tumor immunity.
- The HER-2 peptide E75 is an immunodominant CTL epitope found in ovarian and breast cancers.
- Understanding the activation of CD8+ T cells by tumor antigens is crucial for cancer immunotherapy.
Purpose of the Study:
- To investigate the ability of the HER-2 peptide E75 to activate effector functions in CD8+ T cells from healthy individuals.
- To compare the immune response to E75 with responses to other tumor antigens and an influenza peptide.
- To explore the potential for natural immunosurveillance mediated by tumor antigen-reactive CD8+ T cells.
Main Methods:
- Freshly isolated CD8+ cells and peripheral blood mononuclear cells (PBMCs) from healthy donors were stimulated with tumor-associated antigen (TAA) peptides, including E75, folate binding protein (FBP), and amino-enhancer of split of Notch (AES).
- Interferon-gamma (IFN-γ) and Interleukin-2 (IL-2) production by CD8+ cells, and IL-12 production by antigen-presenting cells (APCs) were measured.
- Responses were compared to those induced by the influenza matrix peptide (M1: 58-66) and assessed for dose-dependency and co-stimulation effects.
Main Results:
- HER-2 peptide E75 rapidly induced IFN-γ in CD8+ cells from 5 out of 6 healthy donors within 20-24 hours, with detectable levels as early as 6 hours.
- IFN-γ induction was antigen concentration-dependent and observed with other tumor peptides (FBP, AES) and HLA-A2 matched tumor cells.
- E75-reactive CD8+ cells induced lower levels of IL-12 and IFN-γ compared to M1 peptide responses, and alphaB7.1 co-stimulation enhanced IL-2 production.
Conclusions:
- Freshly isolated CD8+ T cells from healthy individuals possess the capacity to respond to tumor-associated antigens like HER-2 peptide E75.
- The presence of tumor antigen-reactive CD8+ T cells suggests a potential mechanism for natural immunosurveillance.
- These findings contribute to understanding immune regulation by tumors and may inform the development of cancer immunotherapies.
Abstract:
We investigated the ability of HER-2 peptide E75, which maps an immunodominant CTL epitope for ovarian and breast tumor-associated lymphocytes (TAL), to activate effector functions in freshly isolated CD8+ cells from healthy individuals. IFN-gamma was rapidly induced by E75 within 20-24 h, in five of six healthy donors, in the presence of IL-12 and was detectable as early as 6 h. The IFN-gamma levels were Ag-concentration dependent. Similar results were obtained with peptides mapping CTL epitopes from two other tumor Ag: folate binding protein (FBP) and amino-enhancer of split of Notch (AES). IFN-gamma was also detected, from freshly isolated, unstimulated PBMC in response to HLA-A2 matched tumors + IL-12 but not of IL-12 alone. The major source of IFN-gamma were CD45RO+ CD8+ cells. Induction of IFN-gamma and IL-2 from CD8+ cells and of IL-12 from dendritic cells (DC) by CD8+ cells reactive with E75 mirrored their induction by the influenza matrix peptide (M1: 58-66) in the same individual. Responses to M1 are used to define the presence of activated memory cells in healthy individuals. Compared to M1 responses E75 recognition induced 2-4-fold lower levels of IL-12 from the same APC and IFN-gamma and IL-2 from the same CD8+ cells. At lower Ag concentrations the endogenous IL-12 induced by E75-reactive CD8+ cells did not reach the threshold required to co-stimulate for IFN-gamma. alphaB7.1 synergized with E75 in increasing the overall levels of IL-2 induced within 24 h. The presence of tumor Ag-reactive activated CD8+ cells in healthy individuals may improve our understanding of the mechanisms of immunosurveillance and regulation of immune responses by tumors.
Related Concept Videos
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

